{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:41:06Z","timestamp":1792532466417,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008221","name":"Cure Starts Now Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006641","name":"Cure Brain Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diffuse intrinsic pontine gliomas (DIPGs) and other H3K27M-mutated diffuse midline gliomas (DMGs) are brain tumors that primarily affect children. Radiotherapy is the standard of care but only provides only temporary symptomatic relief due to radioresistance. Although hypoxia is a major driver of radioresistance in other tumors, there is no definitive evidence that DIPGs are hypoxic. Diffuse intrinsic pontine gliomas often contain histone mutations, which alter tumor metabolism and are also associated with radioresistance. Our objective was to identify the metabolic profiles of DIPG cells, detect hypoxia signatures, and uncover metabolism-linked mechanisms of radioresistance to improve tumor radiosensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using DIPG models combined with clinical datasets, we examined mitochondrial metabolism and signatures of hypoxia. We explored DIPG reliance on mitochondrial metabolism using extracellular flux assays and targeted metabolomics. In vitro and in vivo models were used to explore the mechanisms of targeting mitochondrial bioenergetics and hypoxia for radiosensitization. Treatment-induced transcriptomics and metabolomics were also investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comprehensive analyses of DIPG cells show signatures of enhanced oxidative phosphorylation (OXPHOS). We also identified increased expression of specific OXPHOS-related genes and signatures of hypoxia gene expression in datasets obtained from DIPG patients. We found the presence of hypoxia in orthotopic mouse models bearing DIPG tumors. These findings enabled us to develop a proof-of-concept treatment strategy to enhance radiosensitivity of DIPGs in vitro and in animal models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Diffuse intrinsic pontine glioma cells rely on mitochondrial metabolism for growth, and targeting mitochondria disrupts bioenergetics, alleviates hypoxia, and enhances radiosensitivity. These findings warrant further exploration of OXPHOS inhibition as a radiosensitizing strategy for DIPG treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noae255","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T23:22:06Z","timestamp":1732144926000},"page":"1061-1075","source":"Crossref","is-referenced-by-count":18,"title":["Inhibition of mitochondrial bioenergetics and hypoxia to radiosensitize diffuse intrinsic pontine glioma"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2435-2150","authenticated-orcid":false,"given":"Han","family":"Shen","sequence":"first","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiqa","family":"Mudassar","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyong","family":"Ma","sequence":"additional","affiliation":[{"name":"Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, The Ministry of Education, College of Pharmacy, Chongqing Medical University , Chongqing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, The Ministry of Education, College of Pharmacy, Chongqing Medical University , Chongqing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Bal","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney , Sydney, NSW ,","place":["Australia"]},{"name":"Charles Perkins Centre, The University of Sydney , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quy-Susan","family":"Huynh","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Chang","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prunella","family":"Ing","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winny","family":"Varikatt","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Lai","sequence":"additional","affiliation":[{"name":"Westmead Research Hub Core Facilities, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gloss","sequence":"additional","affiliation":[{"name":"Westmead Research Hub Core Facilities, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Holst","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, UNSW Sydney , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine M","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney , Sydney, NSW ,","place":["Australia"]},{"name":"Children\u2019s Cancer Research Unit, The Children\u2019s Hospital at Westmead , Westmead, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Gee","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney , Sydney, NSW ,","place":["Australia"]},{"name":"Western Sydney Radiation Oncology Network, Western Sydney Local Health District ,\u00a0 Sydney, NSW ,","place":["Australia"]},{"name":"Genome Integrity Unit,\u00a0Children\u2019s Medical Research Institute , Westmead, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-7166","authenticated-orcid":false,"given":"Kristina M","family":"Cook","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney , Sydney, NSW ,","place":["Australia"]},{"name":"Charles Perkins Centre, The University of Sydney , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hau","sequence":"additional","affiliation":[{"name":"Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research , Westmead, NSW ,","place":["Australia"]},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney , Sydney, NSW ,","place":["Australia"]},{"name":"Western Sydney Radiation Oncology Network, Western Sydney Local Health District , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"3","key":"2025052712372654500_CIT0001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet."},{"issue":"7384","key":"2025052712372654500_CIT0002","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature."},{"issue":"3","key":"2025052712372654500_CIT0003","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"3","key":"2025052712372654500_CIT0004","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ccell.2020.07.008","article-title":"Integrated metabolic and epigenomic reprograming by H3K27M mutations in diffuse intrinsic pontine gliomas","volume":"38","author":"Chung","year":"2020","journal-title":"Cancer Cell."},{"issue":"11","key":"2025052712372654500_CIT0005","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin Cancer Res."},{"key":"2025052712372654500_CIT0006","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fcell.2017.00043","article-title":"Metabolic reprogramming in glioma","volume":"5","author":"Strickland","year":"2017","journal-title":"Front Cell Dev Biol."},{"issue":"2","key":"2025052712372654500_CIT0007","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11060-015-1726-0","article-title":"Citrate concentrations increase with hypoperfusion in pediatric diffuse intrinsic pontine glioma","volume":"122","author":"Yeom","year":"2015","journal-title":"J Neurooncol."},{"key":"2025052712372654500_CIT0008","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia (Auckl)."},{"issue":"4","key":"2025052712372654500_CIT0009","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/1754-9485.13416","article-title":"Improving the synergistic combination of programmed death-1\/programmed death ligand-1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment","volume":"66","author":"Mudassar","year":"2022","journal-title":"J Med Imag Radiat Oncol."},{"issue":"1","key":"2025052712372654500_CIT0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13046-020-01639-2","article-title":"Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas","volume":"39","author":"Shen","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2025052712372654500_CIT0011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"269","key":"2025052712372654500_CIT0012","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal."},{"issue":"2","key":"2025052712372654500_CIT0013","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/sj.bjc.6605450","article-title":"Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene","volume":"102","author":"Buffa","year":"2010","journal-title":"Br J Cancer."},{"issue":"23","key":"2025052712372654500_CIT0014","doi-asserted-by":"crossref","first-page":"14276","DOI":"10.1021\/acs.jmedchem.0c01013","article-title":"Why all the fuss about Oxidative Phosphorylation (OXPHOS)","volume":"63","author":"Xu","year":"2020","journal-title":"J Med Chem."},{"issue":"4","key":"2025052712372654500_CIT0015","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccell.2023.03.007","article-title":"Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities","volume":"41","author":"Sun","year":"2023","journal-title":"Cancer Cell."},{"issue":"6","key":"2025052712372654500_CIT0016","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/S0021-9258(18)69126-4","article-title":"The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration","volume":"263","author":"Wilson","year":"1988","journal-title":"J Biol Chem."},{"issue":"2","key":"2025052712372654500_CIT0017","doi-asserted-by":"crossref","first-page":"101370","DOI":"10.1016\/j.xpro.2022.101370","article-title":"Measurement of cerebral oxygen pressure in living mice by two-photon phosphorescence lifetime microscopy","volume":"3","author":"Erlebach","year":"2022","journal-title":"Star Protocol."},{"issue":"1","key":"2025052712372654500_CIT0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat Chem Biol."},{"issue":"614","key":"2025052712372654500_CIT0019","doi-asserted-by":"crossref","first-page":"eabc0497","DOI":"10.1126\/scitranslmed.abc0497","article-title":"Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas","volume":"13","author":"Panwalkar","year":"2021","journal-title":"Sci Transl Med."},{"issue":"11","key":"2025052712372654500_CIT0020","doi-asserted-by":"crossref","first-page":"102536","DOI":"10.1016\/j.jbc.2022.102536","article-title":"Intermittent hypoxia enhances the expression of hypoxia inducible factor HIF1A through histone demethylation","volume":"298","author":"Martinez","year":"2022","journal-title":"J Biol Chem."},{"issue":"16","key":"2025052712372654500_CIT0021","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1073\/pnas.1820989116","article-title":"Target identification reveals lanosterol synthase as a vulnerability in glioma","volume":"116","author":"Phillips","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"2025052712372654500_CIT0022","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cmet.2016.09.005","article-title":"Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers","volume":"24","author":"Liu","year":"2016","journal-title":"Cell Metab."},{"issue":"7506","key":"2025052712372654500_CIT0023","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature."},{"issue":"12","key":"2025052712372654500_CIT0024","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.tcb.2023.03.013","article-title":"The Warburg effect: a signature of mitochondrial overload","volume":"33","author":"Wang","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"8","key":"2025052712372654500_CIT0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.trecan.2021.03.001","article-title":"Therapeutic repurposing of biguanides in cancer","volume":"7","author":"Zhao","year":"2021","journal-title":"Trends Cancer."},{"issue":"6","key":"2025052712372654500_CIT0026","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41416-023-02204-2","article-title":"Is it still worth pursuing the repurposing of metformin as a cancer therapeutic","volume":"128","author":"Lord","year":"2023","journal-title":"Br J Cancer."},{"issue":"1","key":"2025052712372654500_CIT0027","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/neuonc\/noz140","article-title":"Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas","volume":"22","author":"Shen","year":"2020","journal-title":"Neuro Oncol"},{"issue":"24","key":"2025052712372654500_CIT0028","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1158\/1078-0432.CCR-13-1787","article-title":"Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response","volume":"19","author":"Zannella","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2025052712372654500_CIT0029","doi-asserted-by":"crossref","first-page":"e170329","DOI":"10.1172\/JCI170329","article-title":"PI3K\/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma","volume":"134","author":"Duchatel","year":"2024","journal-title":"J Clin Invest."},{"issue":"13","key":"2025052712372654500_CIT0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133316","article-title":"Phenformin as an anticancer agent: challenges and prospects","volume":"20","author":"Garcia Rubino","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"8","key":"2025052712372654500_CIT0031","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat Rev Endocrinol."},{"issue":"4","key":"2025052712372654500_CIT0032","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/156652409788167087","article-title":"Hypoxia and radiation therapy: past history, ongoing research, and future promise","volume":"9","author":"Rockwell","year":"2009","journal-title":"Curr Mol Med."},{"issue":"11","key":"2025052712372654500_CIT0033","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1158\/2159-8290.CD-23-0131","article-title":"Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways","volume":"13","author":"Venneti","year":"2023","journal-title":"Cancer Discov."},{"issue":"14","key":"2025052712372654500_CIT0034","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.3390\/ijms22147265","article-title":"Targeting glucose metabolism of cancer cells with dichloroacetate to radiosensitize high-grade gliomas","volume":"22","author":"Cook","year":"2021","journal-title":"Int J Mol Sci."},{"key":"2025052712372654500_CIT0035","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1038\/s41467-024-52973-4","article-title":"Therapeutic targeting of differentiation state-dependent metabolic vulnerabilities in diffuse midline glioma","volume":"15","author":"Mbah","year":"2022","journal-title":"Nat Commun."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noae255\/60785439\/noae255.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/4\/1061\/60785439\/noae255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/4\/1061\/60785439\/noae255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:37:40Z","timestamp":1748349460000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/27\/4\/1061\/7906844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,11,22]]},"published-print":{"date-parts":[[2025,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noae255","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,11,22]]}}}